Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors within the central nervous process, conolidine modulates alternate molecular targets. A Science Innovations study uncovered that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availabili... https://reidafhoq.mybuzzblog.com/18965896/the-basic-principles-of-alternative-natural-pain-relief-to-replace-traditional-painkillers